SYNPO and Glomerular sclerosis: Infused MSCs repair the podocyte and renal interstitial injury by upregulating synaptopodin expression and downregulating TGF-β1 expression, resulting in that the manifestations such as glomerular sclerosis, mesangial expansion, and tubular dilatation were obviously improved.